Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 47412101000001113 | Beta-Prograne (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 47412201000001118 | Beta-Prograne | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Beta-Prograne | Is a | Trade family | true | Inferred relationship | Existential restriction modifier | ||
| Beta-Prograne | Has trade family group | Beta-Prograne | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Beta-Prograne 160mg modified-release capsules (Tillomed Laboratories) | Is a | True | Beta-Prograne | Inferred relationship | Existential restriction modifier | |
| Beta-Prograne 160mg modified-release capsules (Teva UK Ltd) | Is a | True | Beta-Prograne | Inferred relationship | Existential restriction modifier | |
| Beta-Prograne 160mg modified-release capsules (Accord Healthcare Ltd) | Is a | True | Beta-Prograne | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR